Clinical Trial Update: Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users [Phase 3]

View source ↗

Summary

Phase 3 clinical trial completed evaluating an antidepressant to reduce HIV risk behaviors in depressed intravenous drug users.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Major Depressive Disorder
• Substance Use Disorder

Drugs mentioned

• Unspecified antidepressant medication

Snippet

Sponsor: Butler Hospital | Conditions: Depression, Substance-Related Disorders | Phase 3 | Status: COMPLETED